In anti-drug Sweden, investors take shine to cannabis stocks

STOCKHOLM(Reuters) – Growing numbers of Swedish investors are getting a buzz from trading in listed marijuana stocks even though the country has some of Europe’s most restrictive drug laws.

FILE PHOTO: A worker collects cuttings from a marijuana plant at the Canopy Growth Corporation facility in Smiths Falls, Ontario, Canada, January 4, 2018. REUTERS/Chris Wattie/File Photo

Shares in companies including Canadian cannabis producers Aurora and Canopy Growth and Sweden’s Heliospectra, which makes lighting for greenhouses that can be used to grow the plant, were the most heavily traded sector in January and February at online stockbroker Nordnet.

While private investors sold heavyweight Swedish stocks such as H&M, Nordea and Ericsson, cannabis stocks drew in around 700 million Swedish crowns ($85 million) over the period.

“It feels like a Klondyke rush. There is a new, big market opening up,” said Joakim Bornold at Nordnet. Investors are betting on cannabis as a growth market as a number of American states, including California, legalize marijuana used in healing for at least 3,000 years and smoked recreationally — and often illegally — around the globe.


Continue reading at

About Reuters

Since 1850, we have experimented, invented, and created content and news solutions to become the world’s leading international news agency. Always at the forefront of real-time breaking news and high-impact global multimedia content, we are constantly innovating our products and services to meet your business needs. Whether we are serving broadcasters, publishers, brands, agencies, or direct to consumers, Reuters provides award-winning coverage of the day’s most important topics, including: business, finance, politics, sports, entertainment, technology, health, environment, and much more.